About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Retailers
- Sub-Industry: Health Care Distributors
- Symbol: NYSE:MCK
- CUSIP: 58155Q10
- Web: www.mckesson.com
Capitalization:- Market Cap: $31.70308 billion
- Outstanding Shares: 210,261,000
Average Prices:- 50 Day Moving Avg: $151.86
- 200 Day Moving Avg: $153.66
- 52 Week Range: $114.53 - $169.29
P/E:- Trailing P/E Ratio: 6.73
- Foreward P/E Ratio: 11.54
- P/E Growth: 4.34
Sales & Book Value:- Annual Revenue: $199.85 billion
- Price / Sales: 0.16
- Book Value: $53.76 per share
- Price / Book: 2.76
Dividend:- Annual Dividend: $1.36
- Dividend Yield: 0.9%
Profitability:- EBITDA: $3.94 billion
- Net Margins: 2.42%
- Return on Equity: 25.76%
- Return on Assets: 4.34%
Debt:- Debt-to-Equity Ratio: 0.64%
- Current Ratio: 1.05%
- Quick Ratio: 0.62%
Misc:- Average Volume: 1.70 million shs.
- Beta: 1.17
- Short Ratio: 1.89
Frequently Asked Questions for McKesson Corporation (NYSE:MCK)
What is McKesson Corporation's stock symbol?
McKesson Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson Corporation pay dividends? What is the dividend yield for McKesson Corporation?
McKesson Corporation announced a quarterly dividend on Wednesday, July 26th. Investors of record on Friday, September 1st will be given a dividend of $0.34 per share on Monday, October 2nd. This represents a $1.36 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Wednesday, August 30th. This is a boost from McKesson Corporation's previous quarterly dividend of $0.28. View McKesson Corporation's Dividend History.
How were McKesson Corporation's earnings last quarter?
McKesson Corporation (NYSE:MCK) issued its quarterly earnings data on Thursday, July, 27th. The company reported $2.46 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $2.81 by $0.35. The company earned $51.05 billion during the quarter, compared to analyst estimates of $51.22 billion. McKesson Corporation had a net margin of 2.42% and a return on equity of 25.76%. The business's quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the company posted $3.50 EPS. View McKesson Corporation's Earnings History.
When will McKesson Corporation make its next earnings announcement?
Where is McKesson Corporation's stock going? Where will McKesson Corporation's stock price be in 2017?
16 equities research analysts have issued 12-month target prices for McKesson Corporation's shares. Their predictions range from $131.00 to $193.00. On average, they anticipate McKesson Corporation's share price to reach $171.19 in the next year. View Analyst Ratings for McKesson Corporation.
What are analysts saying about McKesson Corporation stock?
Here are some recent quotes from research analysts about McKesson Corporation stock:
- 1. According to Zacks Investment Research, "Over the past three months, McKesson has been trading above the broader Medical/Dental – Supplies industry. Looking forward, management expects to gain with the gradually stabilizing generic and branded markets. The company recently posted stable numbers for the fourth-quarter fiscal 2017 (ended Mar 31, 2017) wherein earnings beat the Zacks Consensus Estimate, courtesy of a strong performance in the Distribution Solutions division. To boost growth the company has acquired CoverMyMeds for approximately $1.1 billion in the recent past. Also, cost-savings efforts remain encouraging. Furthermore, an inexpensive valuation and rising estimate revision trend for the current year indicates a pocket of opportunity for the stock. On the flip side, stiff competition, currency headwind and reimbursement issues remain challenges." (7/12/2017)
- 2. Citigroup Inc. analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)
Who are some of McKesson Corporation's key competitors?
Some companies that are related to McKesson Corporation include Allergan PLC. (AGN), Stryker Corporation (SYK), Aetna (AET), Anthem (ANTM), Becton, Dickinson and Company (BDX), Fresenius SE (FSNUY), Regeneron Pharmaceuticals (REGN), Takeda Pharmaceutical (TKPYY), Shire PLC (SHPG), Intuitive Surgical (ISRG), Boston Scientific Corporation (BSX), Vertex Pharmaceuticals Incorporated (VRTX), Humana (HUM), Baxter International (BAX), Express Scripts Holding Company (ESRX), Zoetis (ZTS), Alexion Pharmaceuticals (ALXN) and Illumina (ILMN).
Who are McKesson Corporation's key executives?
McKesson Corporation's management team includes the folowing people:
- John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer
- James A. Beer, Chief Financial Officer, Executive Vice President
- Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer
- Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel
- Jorge L. Figueredo, Executive Vice President - Human Resources
- Paul Coleman Julian, Executive Vice President, Group President
- Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development
- Edward A. Mueller, Lead Independent Director
- Andrew D. Bryant, Independent Director
- N. Anthony Coles Jr., M.D., Independent Director
Who owns McKesson Corporation stock?
McKesson Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include Nationwide Fund Advisors (0.13%), PGGM Investments (0.11%), River & Mercantile Asset Management LLP (0.08%), Shell Asset Management Co. (0.05%), BB&T Corp (0.04%) and APG Asset Management N.V. (0.03%). Company insiders that own McKesson Corporation stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson Corporation.
Who sold McKesson Corporation stock? Who is selling McKesson Corporation stock?
McKesson Corporation's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., PGGM Investments, Diamond Hill Capital Management Inc., Shikiar Asset Management Inc., Meeder Asset Management Inc., BB&T Corp, State Treasurer State of Michigan and Whittier Trust Co. of Nevada Inc.. Company insiders that have sold McKesson Corporation stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs, Marie L/Ca Knowles and Wayne A Budd. View Insider Buying and Selling for McKesson Corporation.
Who bought McKesson Corporation stock? Who is buying McKesson Corporation stock?
McKesson Corporation's stock was bought by a variety of institutional investors in the last quarter, including River & Mercantile Asset Management LLP, Shell Asset Management Co., Assenagon Asset Management S.A., Nationwide Fund Advisors, Ingalls & Snyder LLC, Butensky & Cohen Financial Security Inc., FormulaFolio Investments LLC and Mycio Wealth Partners LLC. Company insiders that have bought McKesson Corporation stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson Corporation.
How do I buy McKesson Corporation stock?
Shares of McKesson Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson Corporation's stock price today?
One share of McKesson Corporation stock can currently be purchased for approximately $148.30.
MarketBeat Community Rating for McKesson Corporation (NYSE MCK)MarketBeat's community ratings are surveys of what our community members think about McKesson Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for McKesson Corporation (NYSE:MCK) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 7 Hold Ratings, 8 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.44) |
| Consensus Price Target: | $171.19 (15.43% upside) |
Consensus Price Target History for McKesson Corporation (NYSE:MCK)
Analysts' Ratings History for McKesson Corporation (NYSE:MCK)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/18/2017 | Jefferies Group LLC | Set Price Target | Hold | $165.00 | N/A |  |
| 10/16/2017 | Needham & Company LLC | Set Price Target | Buy | $179.00 | N/A | |
| 10/10/2017 | Cowen and Company | Upgrade | Market Perform -> Outperform | $176.00 -> $189.00 | N/A | |
| 9/19/2017 | Royal Bank Of Canada | Initiated Coverage | Sector Perform -> Sector Perform | $168.00 | Low | |
| 9/19/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $175.00 -> $178.00 | Low | |
| 9/14/2017 | Morgan Stanley | Downgrade | Overweight -> Equal Weight | $184.00 -> $172.00 | High | |
| 6/29/2017 | Leerink Swann | Boost Price Target | Market Perform | $170.00 | Medium | |
| 6/4/2017 | Barclays PLC | Set Price Target | Buy | $187.00 | Low | |
| 5/30/2017 | Mizuho | Boost Price Target | Neutral -> Neutral | $147.00 -> $168.00 | Low | |
| 5/23/2017 | J P Morgan Chase & Co | Upgrade | Neutral -> Overweight | $189.00 | Medium | |
| 4/17/2017 | Evercore ISI | Reiterated Rating | Outperform | $166.00 | Low | |
| 3/6/2017 | Citigroup Inc. | Boost Price Target | Buy | $169.00 -> $175.00 | N/A | |
| 3/3/2017 | Credit Suisse Group | Reiterated Rating | Sell | | N/A | |
| 1/18/2017 | Avondale Partners | Upgrade | Market Perform -> Outperform | $157.00 -> $193.00 | N/A | |
| 11/11/2016 | Standpoint Research | Downgrade | Buy -> Hold | | N/A | |
| 10/28/2016 | Deutsche Bank AG | Downgrade | Buy -> Hold | $196.00 -> $153.00 | N/A | |
| 9/19/2016 | Argus | Reiterated Rating | Hold | | N/A | |
| 9/16/2016 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $210.00 -> $189.00 | N/A | |
| 6/30/2016 | Bank of America Corporation | Reiterated Rating | Hold | | N/A | |
| 6/29/2016 | FBR & Co | Reiterated Rating | Buy | $210.00 | N/A | |
| 6/1/2016 | Raymond James Financial, Inc. | Downgrade | Strong-Buy -> Outperform | | N/A | |
(Data available from 10/24/2015 forward)
Earnings History for McKesson Corporation (NYSE:MCK)Earnings History by Quarter for McKesson Corporation (NYSE MCK)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/26/2017 | | $2.85 | | | | | N/A | |
| 7/27/2017 | Q1 2018 | $2.81 | $2.46 | $51.22 billion | $51.05 billion | View | N/A | |
| 5/18/2017 | Q4 17 | $3.04 | $3.39 | $49.48 billion | $48.71 billion | View | N/A | |
| 1/25/2017 | Q317 | $2.95 | $3.03 | $50.71 billion | $50.13 billion | View | N/A | |
| 10/27/2016 | Q217 | $3.05 | $2.94 | $24.16 billion | $49.96 billion | View | Listen | |
| 7/27/2016 | Q117 | $3.33 | $3.50 | $50.32 billion | $49.73 billion | View | Listen | |
| 5/4/2016 | Q416 | $3.14 | $2.44 | $46.83 billion | $46.68 billion | View | N/A | |
| 1/27/2016 | Q316 | $3.13 | $3.18 | $48.97 billion | $47.90 billion | View | Listen | |
| 10/29/2015 | Q216 | $2.99 | $3.31 | $47.85 billion | $48.60 billion | View | Listen | |
| 7/29/2015 | Q116 | $2.89 | $3.14 | $46.02 billion | $47.50 billion | View | Listen | |
| 5/12/2015 | Q415 | $2.75 | $2.94 | $45.00 billion | $44.93 billion | View | Listen | |
| 2/5/2015 | Q315 | $2.61 | $2.89 | $44.81 billion | $47.01 billion | View | N/A | |
| 10/28/2014 | Q215 | $2.73 | $2.79 | $42.99 billion | $44.76 billion | View | N/A | |
| 7/31/2014 | Q115 | $2.34 | $2.49 | $40.65 billion | $44.06 billion | View | N/A | |
| 5/12/2014 | Q414 | $2.40 | $2.55 | $35.89 billion | $38.14 billion | View | N/A | |
| 1/31/2014 | Q314 | $1.85 | $1.45 | $38.57 billion | $34.30 billion | View | N/A | |
| 10/24/2013 | Q214 | $2.03 | $2.27 | $32.16 billion | $33.00 billion | View | Listen | |
| 7/25/2013 | Q1 2014 | $1.71 | $2.07 | $32.60 billion | $32.20 billion | View | Listen | |
| 5/7/2013 | Q4 2013 | $2.30 | $1.45 | $32.01 billion | $30.62 billion | View | Listen | |
| 1/31/2013 | Q3 2013 | $1.62 | $1.41 | $30.81 billion | $31.19 billion | View | Listen | |
| 10/25/2012 | | $1.78 | $1.92 | | | View | N/A | |
| 7/26/2012 | | $1.48 | $1.55 | | | View | N/A | |
| 4/30/2012 | | $2.04 | $2.09 | | | View | N/A | |
| 1/30/2012 | | $1.38 | $1.40 | | | View | N/A | |
| 10/25/2011 | | $1.38 | $1.63 | | | View | N/A | |
| 7/28/2011 | | $1.10 | $1.27 | | | View | N/A | |
| 5/3/2011 | | $1.60 | $1.66 | | | View | N/A | |
| 1/31/2011 | | $1.12 | $1.12 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for McKesson Corporation (NYSE:MCK)2017 EPS Consensus Estimate: $12.80
2018 EPS Consensus Estimate: $11.96
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $3.36 | $3.40 | $3.38 |
| Q2 2017 | 2 | $3.10 | $3.10 | $3.10 |
| Q3 2017 | 2 | $2.85 | $3.46 | $3.16 |
| Q4 2017 | 3 | $2.99 | $3.51 | $3.17 |
| Q1 2018 | 2 | $2.85 | $2.88 | $2.87 |
| Q2 2018 | 2 | $2.80 | $2.82 | $2.81 |
| Q3 2018 | 2 | $2.80 | $2.90 | $2.85 |
| Q4 2018 | 2 | $3.08 | $3.78 | $3.43 |
(Data provided by Zacks Investment Research)
Current Dividend Information for McKesson Corporation (NYSE:MCK)| Most Recent Dividend: | 10/2/2017 |
| Annual Dividend: | $1.36 |
| Dividend Yield: | 0.92% |
| Dividend Growth: | 10.10% (3 Year Average) |
| Payout Ratio: | 6.07% (Trailing 12 Months of Earnings)
11.25% (Based on This Year's Estimates)
10.58% (Based on Next Year's Estimates)
|
| Track Record: | 4 Years of Consecutive Dividend Growth |
Dividend History by Quarter for McKesson Corporation (NYSE MCK)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/26/2017 | quarterly | $0.34 | 0.84% | 8/30/2017 | 9/1/2017 | 10/2/2017 |
| 5/24/2017 | quarterly | $0.28 | 0.69% | 6/1/2017 | 6/5/2017 | 7/3/2017 |
| 1/25/2017 | quarterly | $0.28 | 0.81% | 2/27/2017 | 3/1/2017 | 4/3/2017 |
| 10/27/2016 | quarterly | $0.28 | 0.9% | 11/29/2016 | 12/1/2016 | 1/2/2017 |
| 7/26/2016 | quarterly | $0.28 | 0.57% | 8/30/2016 | 9/1/2016 | 10/3/2016 |
| 5/25/2016 | quarterly | $0.28 | 0.62% | 6/2/2016 | 6/6/2016 | 7/1/2016 |
| 1/27/2016 | quarterly | $0.28 | 0.7% | 2/26/2016 | 3/1/2016 | 4/1/2016 |
| 10/30/2015 | quarterly | $0.28 | 0.62% | 11/27/2015 | 12/1/2015 | 1/4/2016 |
| 7/29/2015 | quarterly | $0.28 | 0.52% | 8/28/2015 | 9/1/2015 | 10/1/2015 |
| 5/27/2015 | quarterly | $0.24 | 0.4% | 6/4/2015 | 6/8/2015 | 7/1/2015 |
| 1/29/2015 | quarterly | $0.24 | 0.44% | 2/26/2015 | 3/2/2015 | 4/1/2015 |
| 10/21/2014 | quarterly | $0.24 | 0.49% | 11/26/2014 | 12/1/2014 | 1/2/2015 |
| 7/30/2014 | quarterly | $0.24 | 0.49% | 8/28/2014 | 9/2/2014 | 10/1/2014 |
| 5/28/2014 | quarterly | $0.24 | 0.51% | 6/5/2014 | 6/9/2014 | 7/1/2014 |
| 1/29/2014 | quarterly | $0.24 | 0.54% | 2/27/2014 | 3/3/2014 | 4/1/2014 |
| 10/25/2013 | quarterly | $0.24 | 0.63% | 11/27/2013 | 12/2/2013 | 1/2/2014 |
| 7/25/2013 | quarterly | $0.24 | 0.77% | 8/29/2013 | 9/3/2013 | 10/1/2013 |
| 5/22/2013 | quarterly | $0.22 | 0.68% | 6/5/2013 | 6/7/2013 | 7/1/2013 |
| 1/30/2013 | quarterly | $0.20 | 0.76% | 2/27/2013 | 3/1/2013 | 4/1/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for McKesson Corporation (NYSE:MCK)Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 85.29%
Insider Trades by Quarter for McKesson Corporation (NYSE:MCK)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/29/2017 | John H Hammergren | CEO | Sell | 99,000 | $153.89 | $15,235,110.00 | |
| 9/28/2017 | John H Hammergren | CEO | Sell | 100,000 | $153.51 | $15,351,000.00 | |
| 9/27/2017 | John H Hammergren | CEO | Sell | 100,000 | $155.30 | $15,530,000.00 | |
| 9/26/2017 | John H Hammergren | CEO | Sell | 100,000 | $154.81 | $15,481,000.00 | |
| 9/25/2017 | John H Hammergren | CEO | Sell | 100,000 | $154.15 | $15,415,000.00 | |
| 9/22/2017 | John H. Hammergren | Chairman | Sell | 225,000 | $151.67 | $34,125,750.00 | |
| 9/22/2017 | John H. Hammergren | CEO | Sell | 100,000 | $153.53 | $15,353,000.00 | |
| 9/20/2017 | John H. Hammergren | CEO | Sell | 125,000 | $150.18 | $18,772,500.00 | |
| 9/7/2017 | Erin M. Lampert | SVP | Sell | 900 | $155.65 | $140,085.00 | |
| 8/21/2017 | M Christine Jacobs | Director | Sell | 1,083 | $145.43 | $157,500.69 | |
| 7/31/2017 | Marie L/Ca Knowles | Director | Sell | 1,083 | $162.55 | $176,041.65 | |
| 6/1/2017 | John H Hammergren | Chairman | Sell | 38,619 | $163.76 | $6,324,247.44 | |
| 5/31/2017 | Erin M Lampert | SVP | Sell | 809 | $160.66 | $129,973.94 | |
| 5/30/2017 | Erin M Lampert | SVP | Sell | 404 | $160.53 | $64,854.12 | |
| 5/30/2017 | John H Hammergren | Chairman | Sell | 19,316 | $162.31 | $3,135,179.96 | |
| 3/29/2017 | John H Hammergren | Chairman | Sell | 100,500 | $150.44 | $15,119,220.00 | |
| 3/2/2017 | John H Hammergren | Chairman | Sell | 100,500 | $150.49 | $15,124,245.00 | |
| 12/5/2016 | Wayne A. Budd | Director | Sell | 723 | $145.77 | $105,391.71 | |
| 11/30/2016 | Lori A Schechter | EVP | Buy | 692 | $144.52 | $100,007.84 | |
| 11/2/2016 | Susan R Salka | Director | Buy | 1,000 | $136.35 | $136,350.00 | |
| 10/31/2016 | Erin M Lampert | SVP | Sell | 921 | $123.99 | $114,194.79 | |
| 10/3/2016 | Erin M. Lampert | SVP | Sell | 1,739 | $165.94 | $288,569.66 | |
| 9/12/2016 | John H Hammergren | Chairman | Sell | 100,500 | $180.77 | $18,167,385.00 | |
| 9/12/2016 | Wayne A Budd | Director | Sell | 2,309 | $179.70 | $414,927.30 | |
| 9/6/2016 | John H Hammergren | Chairman | Sell | 100,500 | $184.22 | $18,514,110.00 | |
| 8/22/2016 | M Christine Jacobs | Director | Sell | 915 | $193.78 | $177,308.70 | |
| 8/1/2016 | Marie L/Ca Knowles | Director | Sell | 915 | $192.73 | $176,347.95 | |
| 7/14/2016 | James A Beer | CFO | Sell | 5,500 | $199.00 | $1,094,500.00 | |
| 5/25/2016 | John H Hammergren | CEO | Sell | 37,420 | $182.87 | $6,842,995.40 | |
| 5/25/2016 | Patrick Blake | EVP | Sell | 6,322 | $182.87 | $1,156,104.14 | |
| 5/24/2016 | John H Hammergren | CEO | Sell | 18,709 | $182.06 | $3,406,160.54 | |
| 5/24/2016 | Lori A Schechter | EVP | Sell | 107 | $182.06 | $19,480.42 | |
| 5/23/2016 | John H Hammergren | CEO | Sell | 18,718 | $179.33 | $3,356,698.94 | |
| 5/23/2016 | Patrick Blake | EVP | Sell | 3,162 | $179.33 | $567,041.46 | |
| 5/10/2016 | John H Hammergren | CEO | Sell | 101,833 | $170.71 | $17,383,911.43 | |
| 4/25/2016 | John H Hammergren | CEO | Sell | 101,833 | $176.81 | $18,005,092.73 | |
| 4/4/2016 | John H Hammergren | CEO | Sell | 45,300 | $159.00 | $7,202,700.00 | |
| 3/15/2016 | Nigel A Rees | SVP | Sell | 6,000 | $157.59 | $945,540.00 | |
| 2/2/2016 | Susan R Salka | Director | Buy | 1,000 | $156.21 | $156,210.00 | |
| 2/1/2016 | Lori A. Schechter | EVP | Sell | 2,476 | $159.73 | $395,491.48 | |
| 1/4/2016 | John H. Hammergren | CEO | Sell | 101,833 | $194.11 | $19,766,803.63 | |
| 12/1/2015 | John H. Hammergren | CEO | Sell | 101,833 | $190.06 | $19,354,379.98 | |
| 11/24/2015 | John H. Hammergren | CEO | Sell | 56,533 | $190.01 | $10,741,835.33 | |
| 10/12/2015 | John H. Hammergren | CEO | Sell | 101,835 | $190.51 | $19,400,585.85 | |
| 8/13/2015 | Paul C Julian | EVP | Sell | 55,666 | $214.54 | $11,942,583.64 | |
| 7/15/2015 | Paul C Julian | EVP | Sell | 27,833 | $234.04 | $6,514,035.32 | |
| 7/14/2015 | Paul C Julian | EVP | Sell | 27,833 | $232.86 | $6,481,192.38 | |
| 6/17/2015 | Paul C Julian | EVP | Sell | 55,668 | $234.06 | $13,029,652.08 | |
| 5/28/2015 | John H Hammergren | CEO | Sell | 60,000 | $238.53 | $14,311,800.00 | |
| 5/28/2015 | Lori A Schechter | EVP | Sell | 1,468 | $238.22 | $349,706.96 | |
| 5/26/2015 | John H Hammergren | CEO | Sell | 30,062 | $238.97 | $7,183,916.14 | |
| 5/26/2015 | Paul C Julian | EVP | Sell | 15,289 | $238.97 | $3,653,612.33 | |
| 5/22/2015 | Jorge Figueredo | EVP | Sell | 20,775 | $240.11 | $4,988,285.25 | |
| 5/15/2015 | Jorge Figueredo | EVP | Sell | 8,525 | $240.00 | $2,046,000.00 | |
| 2/17/2015 | Randall N Spratt | EVP | Sell | 44,523 | $225.00 | $10,017,675.00 | |
| 2/12/2015 | Randall N Spratt | EVP | Sell | 7,477 | $225.00 | $1,682,325.00 | |
| 2/10/2015 | Alton F Irby III | Director | Sell | 5,000 | $220.76 | $1,103,800.00 | |
| 2/10/2015 | Nigel A Rees | Major Shareholder | Sell | 9,000 | $220.42 | $1,983,780.00 | |
| 1/28/2015 | John H Hammergren | CEO | Sell | 64,521 | $219.52 | $14,163,649.92 | |
| 1/26/2015 | Brian Scott Tyler | EVP | Sell | 5,431 | $216.62 | $1,176,463.22 | |
| 1/26/2015 | John H Hammergren | CEO | Sell | 35,479 | $219.07 | $7,772,384.53 | |
| 1/7/2015 | John H Hammergren | CEO | Sell | 77,100 | $214.00 | $16,499,400.00 | |
| 12/8/2014 | John H Hammergren | CEO | Sell | 12,200 | $214.01 | $2,610,922.00 | |
| 11/28/2014 | Patrick Blake | EVP | Sell | 19,000 | $210.00 | $3,990,000.00 | |
| 11/24/2014 | John H Hammergren | CEO | Sell | 100,000 | $209.25 | $20,925,000.00 | |
| 11/12/2014 | Paul C Julian | EVP | Sell | 74,666 | $202.51 | $15,120,611.66 | |
| 10/31/2014 | Patrick Blake | EVP | Sell | 38,000 | $204.68 | $7,777,840.00 | |
| 10/8/2014 | Paul C Julian | EVP | Sell | 74,667 | $195.86 | $14,624,278.62 | |
| 10/7/2014 | John H Hammergren | CEO | Sell | 100,000 | $197.28 | $19,728,000.00 | |
| 9/10/2014 | Paul C Julian | EVP | Sell | 74,667 | $196.76 | $14,691,478.92 | |
| 8/29/2014 | Jorge Figueredo | EVP | Sell | 24,500 | $195.00 | $4,777,500.00 | |
| 8/8/2014 | M Christine Jacobs | Director | Sell | 2,619 | $189.88 | $497,295.72 | |
| 8/5/2014 | Marie L/Ca Knowles | Director | Sell | 785 | $192.10 | $150,798.50 | |
| 6/2/2014 | Patrick Blake | EVP | Sell | 15,000 | $190.00 | $2,850,000.00 | |
| 5/29/2014 | Paul C Julian | EVP | Sell | 21,057 | $186.89 | $3,935,342.73 | |
| 5/28/2014 | Alton F Irby III | Director | Sell | 4,000 | $182.73 | $730,920.00 | |
| 5/28/2014 | John H Hammergren | CEO | Sell | 125,596 | $183.31 | $23,023,002.76 | |
| 5/28/2014 | Jorge Figueredo | EVP | Sell | 20,542 | $183.30 | $3,765,348.60 | |
| 5/27/2014 | Brian Scott Tyler | EVP | Sell | 3,916 | $183.30 | $717,802.80 | |
| 5/22/2014 | Brian Scott Tyler | EVP | Sell | 8,250 | $184.17 | $1,519,402.50 | |
| 3/21/2014 | Jorge Figueredo | EVP | Sell | 23,684 | $185.81 | $4,400,724.04 | |
| 3/10/2014 | Patrick Blake | EVP | Sell | 38,750 | $180.36 | $6,988,950.00 | |
| 2/4/2014 | Brian Scott Tyler | EVP | Sell | 6,250 | $169.68 | $1,060,500.00 | |
| 1/22/2014 | Alton Irby III | Director | Sell | 1,300 | $167.98 | $218,374.00 | |
| 11/1/2013 | Nigel A Rees | CFO | Sell | 7,000 | $158.72 | $1,111,040.00 | |
| 10/29/2013 | Brian Scott Tyler | EVP | Sell | 8,250 | $153.44 | $1,265,880.00 | |
| 10/11/2013 | Brian Scott Tyler | EVP | Sell | 9,000 | $138.51 | $1,246,590.00 | |
| 10/9/2013 | Paul Julian | EVP | Sell | 84,000 | $134.04 | $11,259,360.00 | |
| 10/8/2013 | Brian Scott Tyler | EVP | Sell | 9,000 | $138.00 | $1,242,000.00 | |
| 9/11/2013 | Paul C Julian | EVP | Sell | 84,000 | $126.20 | $10,600,800.00 | |
| 8/7/2013 | Paul Julian | EVP | Sell | 84,000 | $123.29 | $10,356,360.00 | |
| 8/6/2013 | Marie L/Ca Knowles | Director | Sell | 1,223 | $123.54 | $151,089.42 | |
| 7/30/2013 | Brian Scott Tyler | EVP | Sell | 6,250 | $123.94 | $774,625.00 | |
| 6/19/2013 | Paul C Julian | EVP | Sell | 84,750 | $114.89 | $9,736,927.50 | |
| 6/14/2013 | David M Lawrence | Director | Sell | 7,500 | $114.28 | $857,100.00 | |
| 6/14/2013 | Jorge Figueredo | EVP | Sell | 6,250 | $115.00 | $718,750.00 | |
| 6/10/2013 | Jorge Figueredo | EVP | Sell | 10,000 | $115.00 | $1,150,000.00 | |
| 6/4/2013 | Jorge Figueredo | EVP | Sell | 22,500 | $113.63 | $2,556,675.00 | |
| 5/30/2013 | Laureen Seeger | EVP | Sell | 57,750 | $114.89 | $6,634,897.50 | |
| 5/29/2013 | John H Hammergren | CEO | Sell | 230,484 | $115.21 | $26,554,061.64 | |
| 5/29/2013 | Randall N Spratt | EVP | Sell | 32,226 | $115.21 | $3,712,757.46 | |
| 5/28/2013 | Brian Scott Tyler | EVP | Sell | 6,023 | $116.33 | $700,655.59 | |
| 5/28/2013 | Jeffrey C Campbell | CFO | Sell | 73,102 | $116.33 | $8,503,955.66 | |
| 5/24/2013 | Laureen Seeger | EVP | Sell | 17,250 | $116.50 | $2,009,625.00 | |
| 5/22/2013 | Laureen Seeger | EVP | Sell | 17,250 | $118.13 | $2,037,742.50 | |
| 5/20/2013 | Brian Scott Tyler | EVP | Sell | 5,000 | $117.81 | $589,050.00 | |
| 5/15/2013 | Nigel A Rees | VP | Sell | 8,000 | $116.00 | $928,000.00 | |
| 5/10/2013 | Brian Scott Tyler | EVP | Sell | 6,250 | $115.59 | $722,437.50 | |
| 5/10/2013 | John H Hammergren | CEO | Sell | 75,000 | $115.30 | $8,647,500.00 | |
| 1/18/2013 | Jorge Figueredo | EVP | Sell | 2,500 | $103.22 | $258,050.00 | |
| 1/17/2013 | Laureen Seeger | EVP | Sell | 17,250 | $103.00 | $1,776,750.00 | |
| 9/4/2012 | Paul C Julian | EVP | Sell | 36,250 | $87.02 | $3,154,475.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for McKesson Corporation (NYSE:MCK)
Latest Headlines for McKesson Corporation (NYSE:MCK)
| Source: |
|
Loading headlines, please wait.
McKesson Corporation (MCK) Chart for Tuesday, October, 24, 2017
